Form 4 for CTMX CytomX Therapeutics, Inc.
Accepted 2026-08-05 19:33:34 ET · period of report 2026-08-03 · accession 0001610717-26-000351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-05 19:33 | 2026-08-03 | CTMX | Carvajal Alejandra | CLO | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2026-08-05 19:33 | 2026-08-03 | CTMX | Carvajal Alejandra | CLO | A - Grant | $0.00 | +450.0K | 450.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | A | A | 100,000 | $0.00 | 100,000 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on September 15 of each year, with the first 25% vesting on September 15, 2027, subject to the Reporting Person's continued service to the Issuer through each such date. (F2) Includes 100,000 RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-03 | A | A | 450,000 | $0.00 | 450,000 | D | $3.17 · — to 2036-08-02 | 450,000 Common Stock | (F3) 25% of the shares subject to the option vest on the one-year anniversary measured from August 3, 2026 (the "Vesting Commencement Date"), and 1/48 monthly thereafter such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. |